FindTrial
Sign In

Evaluation of the optimal dose of prophylactic anticoagulation with low-molecular-weight heparine administered subcutaneously to critically ill patients - low-molecular-weight heparin in critically ill patients

Evaluation of the optimal dose of prophylactic anticoagulation with low-molecular-weight heparine administered subcutaneously to critically ill patients - low-molecular-weight heparin in critically ill patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2005-002381-10-DK
Enrollment
80
Registered
2005-06-27
Start date
2005-08-18
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

critically ill patients with sepsis

Interventions

Trade Name: klexane Product Name: enoxaparin Product Code: 6624 Pharmaceutical Form: Injection* INN or Proposed INN: enoxaparin sodium CAS Number: 9041-08-1 Current Sponsor code: 20051111 Other descri

Sponsors

Dept anaesthesiology and intensive care
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Critically ill patients with sepsis admitted to our ICU Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Operation within the 24 hours of investigation and patients with haemodialysis.

Design outcomes

Primary

MeasureTime frame
Main Objective: To evaluate the optimal dose of subcutaneously administered low-molecular-weight heparin(klexane) to critically ill patients.This is evaluated by measuring coagulation parameters especially the anti-1oA activity.;Secondary Objective: none;Primary end point(s): Coagulation parameters are measured for 24 hours after the administration of klexane.—

Countries

Denmark

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026